BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26319391)

  • 1. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
    Iqbal J; Wilcox R; Naushad H; Rohr J; Heavican TB; Wang C; Bouska A; Fu K; Chan WC; Vose JM
    Blood Rev; 2016 Mar; 30(2):89-100. PubMed ID: 26319391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
    Vose J; Armitage J; Weisenburger D;
    J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
    Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
    J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular classification of T-cell lymphomas.
    de Leval L; Bisig B; Thielen C; Boniver J; Gaulard P
    Crit Rev Oncol Hematol; 2009 Nov; 72(2):125-43. PubMed ID: 19233683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
    Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
    Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.
    Iqbal J; Weisenburger DD; Greiner TC; Vose JM; McKeithan T; Kucuk C; Geng H; Deffenbacher K; Smith L; Dybkaer K; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Au WY; Ko YH; Sng I; Armitage JO; Chan WC;
    Blood; 2010 Feb; 115(5):1026-36. PubMed ID: 19965671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.
    Ballester B; Ramuz O; Gisselbrecht C; Doucet G; Loï L; Loriod B; Bertucci F; Bouabdallah R; Devilard E; Carbuccia N; Mozziconacci MJ; Birnbaum D; Brousset P; Berger F; Salles G; Briére J; Houlgatte R; Gaulard P; Xerri L
    Oncogene; 2006 Mar; 25(10):1560-70. PubMed ID: 16288225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review.
    Lone W; Alkhiniji A; Manikkam Umakanthan J; Iqbal J
    Curr Hematol Malig Rep; 2018 Aug; 13(4):318-328. PubMed ID: 29951889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
    Heavican TB; Bouska A; Yu J; Lone W; Amador C; Gong Q; Zhang W; Li Y; Dave BJ; Nairismägi ML; Greiner TC; Vose J; Weisenburger DD; Lachel C; Wang C; Fu K; Stevens JM; Lim ST; Ong CK; Gascoyne RD; Missiaglia E; Lemonnier F; Haioun C; Hartmann S; Pedersen MB; Laginestra MA; Wilcox RA; Teh BT; Yoshida N; Ohshima K; Seto M; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; d'Amore F; Inghirami G; Bertoni F; de Leval L; Gaulard P; Staudt LM; McKeithan TW; Pileri S; Chan WC; Iqbal J
    Blood; 2019 Apr; 133(15):1664-1676. PubMed ID: 30782609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.
    Zhang Y; Lee D; Brimer T; Hussaini M; Sokol L
    Front Oncol; 2020; 10():898. PubMed ID: 32637355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.
    Zettl A; Rüdiger T; Konrad MA; Chott A; Simonitsch-Klupp I; Sonnen R; Müller-Hermelink HK; Ott G
    Am J Pathol; 2004 May; 164(5):1837-48. PubMed ID: 15111330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
    Iqbal J; Wright G; Wang C; Rosenwald A; Gascoyne RD; Weisenburger DD; Greiner TC; Smith L; Guo S; Wilcox RA; Teh BT; Lim ST; Tan SY; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Tubbs RR; Ott G; Geissinger E; Gaulard P; Piccaluga PP; Pileri SA; Au WY; Nakamura S; Seto M; Berger F; de Leval L; Connors JM; Armitage J; Vose J; Chan WC; Staudt LM;
    Blood; 2014 May; 123(19):2915-23. PubMed ID: 24632715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
    Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
    Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker-driven management strategies for peripheral T cell lymphoma.
    Mulvey E; Ruan J
    J Hematol Oncol; 2020 May; 13(1):59. PubMed ID: 32448357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis.
    Ohshima K; Karube K; Kawano R; Tsuchiya T; Suefuji H; Yamaguchi T; Suzumiya J; Kikuchii M
    Int J Oncol; 2004 Sep; 25(3):605-13. PubMed ID: 15289861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive T-cell lymphomas: 2019 updates on diagnosis, risk stratification, and management.
    Zain JM
    Am J Hematol; 2019 Aug; 94(8):929-946. PubMed ID: 31119775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
    Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
    Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of peripheral T-cell lymphomas.
    Piccaluga PP; Tabanelli V; Pileri SA
    Int J Hematol; 2014 Mar; 99(3):219-26. PubMed ID: 24481943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.